These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7931358)

  • 61. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
    Carriere CH; Kang NH; Niles LP
    Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential regulation of caspase-2 in MPP⁺-induced apoptosis in primary cortical neurons.
    Hu HI; Chang HH; Sun DS
    Exp Cell Res; 2015 Mar; 332(1):60-6. PubMed ID: 25645943
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Allogeneic/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson's disease: restoration of mitochondria functions and attenuation of 6-hydroxydopamine-induced neurotoxicity.
    Chang JC; Wu SL; Liu KH; Chen YH; Chuang CS; Cheng FC; Su HL; Wei YH; Kuo SJ; Liu CS
    Transl Res; 2016 Apr; 170():40-56.e3. PubMed ID: 26730494
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Altered expression of Mg(2+) transport proteins during Parkinson's disease-like dopaminergic cell degeneration in PC12 cells.
    Shindo Y; Yamanaka R; Suzuki K; Hotta K; Oka K
    Biochim Biophys Acta; 2016 Aug; 1863(8):1979-84. PubMed ID: 27157538
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relation of superoxide generation and lipid peroxidation to the inhibition of NADH-Q oxidoreductase by rotenone, piericidin A, and MPP+.
    Ramsay RR; Singer TP
    Biochem Biophys Res Commun; 1992 Nov; 189(1):47-52. PubMed ID: 1333196
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Selective A
    Fathalla AM; Soliman AM; Moustafa AA
    Neurosci Lett; 2017 Mar; 643():89-96. PubMed ID: 28213070
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson's disease.
    Chen Y; Zhang DQ; Liao Z; Wang B; Gong S; Wang C; Zhang MZ; Wang GH; Cai H; Liao FF; Xu JP
    Mol Neurodegener; 2015 Mar; 10():4. PubMed ID: 26013581
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pathogenesis of nigral cell death in Parkinson's disease.
    Przedborski S
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S3-7. PubMed ID: 15885625
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Silibinin attenuates MPP⁺-induced neurotoxicity in the substantia nigra in vivo.
    Jung UJ; Jeon MT; Choi MS; Kim SR
    J Med Food; 2014 May; 17(5):599-605. PubMed ID: 24660866
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
    Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO
    Mol Neurobiol; 2019 Jan; 56(1):39-55. PubMed ID: 29675576
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms.
    Gu M; Iravani MM; Cooper JM; King D; Jenner P; Schapira AH
    J Neurochem; 2004 Dec; 91(5):1075-81. PubMed ID: 15569251
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Damage to dopaminergic neurons is mediated by proliferating cell nuclear antigen through the p53 pathway under conditions of oxidative stress in a cell model of Parkinson's disease.
    Li DW; Li GR; Zhang BL; Feng JJ; Zhao H
    Int J Mol Med; 2016 Feb; 37(2):429-35. PubMed ID: 26677001
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells.
    Wang Y; Wang X; Liu L; Wang X
    Neurosci Lett; 2009 Dec; 467(3):212-6. PubMed ID: 19835929
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease.
    Ni Y; Huang H; Chen Y; Cao M; Zhou H; Zhang Y
    Cell Mol Neurobiol; 2017 Mar; 37(2):329-338. PubMed ID: 27151187
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nitration of soluble proteins in organotypic culture models of Parkinson's disease.
    Larsen TR; Söderling AS; Caidahl K; Roepstorff P; Gramsbergen JB
    Neurochem Int; 2008 Feb; 52(3):487-94. PubMed ID: 17900761
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease.
    Marella M; Seo BB; Nakamaru-Ogiso E; Greenamyre JT; Matsuno-Yagi A; Yagi T
    PLoS One; 2008 Jan; 3(1):e1433. PubMed ID: 18197244
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease.
    Hsu M; Srinivas B; Kumar J; Subramanian R; Andersen J
    J Neurochem; 2005 Mar; 92(5):1091-103. PubMed ID: 15715660
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease.
    Corona JC; Gimenez-Cassina A; Lim F; Díaz-Nido J
    J Neurosci Res; 2010 Jul; 88(9):1943-50. PubMed ID: 20143419
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease.
    Kim HG; Ju MS; Kim DH; Hong J; Cho SH; Cho KH; Park W; Lee EH; Kim SY; Oh MS
    Basic Clin Pharmacol Toxicol; 2010 Dec; 107(6):958-64. PubMed ID: 20629656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.